• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性新冠后症状的发生率、症状群和决定因素:基于 COVID RADAR 应用程序的社区居民的基于人群的监测。

Incidence, symptom clusters and determinants of post-acute COVID symptoms: a population-based surveillance in community-dwelling users of the COVID RADAR app.

机构信息

Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

BMJ Open. 2024 Sep 10;14(9):e087235. doi: 10.1136/bmjopen-2024-087235.

DOI:10.1136/bmjopen-2024-087235
PMID:39260850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11409358/
Abstract

OBJECTIVES

This study aims to describe the incidence, symptom clusters and determinants of post-acute COVID symptoms using data from the COVID RADAR app in the Netherlands.

DESIGN

Prospective cohort.

SETTING

General population in the Netherlands from April 2020 to February 2022.

PARTICIPANTS

A total of 1478 COVID RADAR app users, with data spanning 40 days before to 100 days after positive SARS-CoV-2 test.

OUTCOME MEASURES

Incidence and duration of 10 new symptoms that developed during acute infection, defined as 10 days prior and 10 days after positive test. Clustering of these post-acute COVID symptoms and associations between factors known in the acute phase and 100-day symptom persistence.

RESULTS

The most frequent post-acute symptoms were cough, loss of smell or taste and fatigue. At 100 days postinfection, 86 (8%) participants still experienced symptoms. Three post-acute COVID symptom clusters were identified: non-respiratory (headache and fatigue; 49% of participants with post-acute COVID symptoms); olfactory (15%) and respiratory (8%). Vaccination was associated with a lower risk of post-acute COVID symptoms 100 days after infection, although CIs were wide (OR: 0.5; 95% CI: 0.2 to 1.5), but not with non-respiratory symptoms (OR: 1.0; 95% CI: 0.3 to 4.4). Severe acute disease increased the risk of post-acute COVID symptoms (OR: 1.4; 95% CI: 1.2 to 1.5; per additional acute symptom).

CONCLUSIONS

In this cohort of infected community-dwelling app users, 5%-10% experienced post-acute COVID symptoms. The symptoms cluster in several distinct entities, which differ in incidence, patient characteristics and vaccination effects. This suggests multiple mechanisms underlying the development of post-acute COVID symptoms.

摘要

目的

本研究旨在使用荷兰 COVID RADAR 应用程序的数据描述急性 COVID 后症状的发生率、症状群和决定因素。

设计

前瞻性队列研究。

设置

荷兰 2020 年 4 月至 2022 年 2 月的一般人群。

参与者

共有 1478 名 COVID RADAR 应用程序用户,数据涵盖阳性 SARS-CoV-2 检测前 40 天和后 100 天。

主要结局指标

在急性感染期间出现的 10 种新症状的发生率和持续时间,定义为阳性检测前 10 天和后 10 天。这些急性 COVID 后症状的聚类以及急性阶段已知因素与 100 天症状持续存在之间的关联。

结果

最常见的急性后症状是咳嗽、嗅觉或味觉丧失和疲劳。感染后 100 天,86(8%)名参与者仍有症状。确定了三个急性 COVID 后症状群:非呼吸系统(头痛和疲劳;49%有急性 COVID 后症状的参与者);嗅觉(15%)和呼吸系统(8%)。尽管置信区间较宽(OR:0.5;95%CI:0.2 至 1.5),但接种疫苗与感染后 100 天发生急性 COVID 后症状的风险较低相关,但与非呼吸系统症状无关(OR:1.0;95%CI:0.3 至 4.4)。严重急性疾病增加了急性 COVID 后症状的风险(OR:1.4;95%CI:1.2 至 1.5;每增加一个急性症状)。

结论

在本感染社区居住的应用程序用户队列中,5%-10%经历了急性 COVID 后症状。这些症状群在几个不同的实体中聚类,在发病率、患者特征和疫苗接种效果方面存在差异。这表明急性 COVID 后症状的发生存在多种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/5be63df82d75/bmjopen-14-9-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/eab588ef41d4/bmjopen-14-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/daa610b76983/bmjopen-14-9-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/d268a66d9726/bmjopen-14-9-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/5be63df82d75/bmjopen-14-9-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/eab588ef41d4/bmjopen-14-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/daa610b76983/bmjopen-14-9-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/d268a66d9726/bmjopen-14-9-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344a/11409358/5be63df82d75/bmjopen-14-9-g004.jpg

相似文献

1
Incidence, symptom clusters and determinants of post-acute COVID symptoms: a population-based surveillance in community-dwelling users of the COVID RADAR app.急性新冠后症状的发生率、症状群和决定因素:基于 COVID RADAR 应用程序的社区居民的基于人群的监测。
BMJ Open. 2024 Sep 10;14(9):e087235. doi: 10.1136/bmjopen-2024-087235.
2
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中,疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征:一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
3
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
4
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
5
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.估计 2020 年和 2021 年有症状 COVID-19 后持续性疲劳、认知和呼吸症状群个体在全球的比例。
JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
6
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.接种加强针后感染 SARS-CoV-2:一项前瞻性、基于社区的病例对照研究中的疾病和症状特征。
J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28.
7
Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.对 1297 例长新冠患者进行评估的多中心队列的症状特征、病例和症状聚类、临床和人口统计学特征。
BMC Med. 2024 Nov 14;22(1):532. doi: 10.1186/s12916-024-03746-9.
8
Post-COVID-19 Condition Fatigue Outcomes Among Danish Residents.丹麦居民的新冠后疲劳状况结果。
JAMA Netw Open. 2024 Oct 1;7(10):e2434863. doi: 10.1001/jamanetworkopen.2024.34863.
9
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.新冠病毒感染后急性后遗症/新冠后综合征成年患者在急性感染后第二年的持续症状及临床发现:一项基于人群的巢式病例对照研究
PLoS Med. 2025 Jan 23;22(1):e1004511. doi: 10.1371/journal.pmed.1004511. eCollection 2025 Jan.
10
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.开发 SARS-CoV-2 感染后后遗症的定义。
JAMA. 2023 Jun 13;329(22):1934-1946. doi: 10.1001/jama.2023.8823.

本文引用的文献

1
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.新冠病毒感染后急性期到德尔塔和奥密克戎变异株流行时期的后遗症。
N Engl J Med. 2024 Aug 8;391(6):515-525. doi: 10.1056/NEJMoa2403211. Epub 2024 Jul 17.
2
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update.长新冠的流行病学、临床表现、病理生理学和管理:更新。
Mol Psychiatry. 2023 Oct;28(10):4056-4069. doi: 10.1038/s41380-023-02171-3. Epub 2023 Jul 25.
3
Thromboinflammation in long COVID-the elusive key to postinfection sequelae?
长新冠中的血栓炎症——感染后后遗症难以捉摸的关键?
J Thromb Haemost. 2023 Aug;21(8):2020-2031. doi: 10.1016/j.jtha.2023.04.039. Epub 2023 May 11.
4
Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis.感染后 12 个月内通过症状群和时间段对新冠后综合征进行特征描述:系统评价和荟萃分析。
Int J Infect Dis. 2023 Sep;134:1-7. doi: 10.1016/j.ijid.2023.05.003. Epub 2023 May 6.
5
NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel.中性粒细胞胞外诱捕网形成可反映 COVID-19 严重程度和长新冠:来自以色列 2 家中心患者队列研究的新见解。
J Thromb Haemost. 2023 Sep;21(9):2569-2584. doi: 10.1016/j.jtha.2023.02.033. Epub 2023 Apr 11.
6
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.COVID-19 疫苗接种预防和治疗长新冠:系统评价和荟萃分析。
Brain Behav Immun. 2023 Jul;111:211-229. doi: 10.1016/j.bbi.2023.03.022. Epub 2023 Mar 27.
7
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.COVID-19 疫苗接种对长新冠综合征的保护作用:系统评价和荟萃分析。
Vaccine. 2023 Mar 10;41(11):1783-1790. doi: 10.1016/j.vaccine.2023.02.008. Epub 2023 Feb 8.
8
Inflammatory and vascular biomarkers in post-COVID-19 syndrome: A systematic review and meta-analysis of over 20 biomarkers.新冠后综合征中的炎症和血管生物标志物:对20多种生物标志物的系统评价和荟萃分析
Rev Med Virol. 2023 Mar;33(2):e2424. doi: 10.1002/rmv.2424. Epub 2023 Jan 27.
9
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.估计 2020 年和 2021 年有症状 COVID-19 后持续性疲劳、认知和呼吸症状群个体在全球的比例。
JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
10
Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.医护人员中因感染而无需住院的情况下,BNT162b2 疫苗接种与长新冠之间的关联。
JAMA. 2022 Aug 16;328(7):676-678. doi: 10.1001/jama.2022.11691.